Highlights of Thirty-Year Experience of Laser Use at the Florence (Italy) Department of Dermatology
Piero Campolmi(University of Florence), Silvia Moretti(University of Insubria), Torello Lotti(University of Zurich), Andrea Bassi(Azienda Usl Toscana Centro), Paolo Bonan(University of Florence), Nicola Bruscino(University of Florence), Michela Troiano(University of Florence), Meena Arunachalam(Daiichi Sankyo (United States)), Giovanni Cannarozzo(University of Florence)
Cited by 35
Related Papers
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
|The Lancet Oncology|2019|486
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
|Nature Genetics|2016|362
New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions
|Pigment Cell Research|2002|298
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
|Journal of the European Academy of Dermatology and Venereology|2020|248